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Abstract
Background: The key roles of epistatic interactions between multiple genetic variants in the
pathogenesis of complex diseases notwithstanding, the detection of such interactions remains a
great challenge in genome-wide association studies. Although some existing multi-locus approaches
have shown their successes in small-scale case-control data, the "combination explosion" course
prohibits their applications to genome-wide analysis. It is therefore indispensable to develop new
methods that are able to reduce the search space for epistatic interactions from an astronomic
number of all possible combinations of genetic variants to a manageable set of candidates.
Results: We studied case-control data from the viewpoint of binary classification. More precisely,
we treated single nucleotide polymorphism (SNP) markers as categorical features and adopted the
random forest to discriminate cases against controls. On the basis of the gini importance given by
the random forest, we designed a sliding window sequential forward feature selection (SWSFS)
algorithm to select a small set of candidate SNPs that could minimize the classification error and
then statistically tested up to three-way interactions of the candidates. We compared this approach
with three existing methods on three simulated disease models and showed that our approach is
comparable to, sometimes more powerful than, the other methods. We applied our approach to
a genome-wide case-control dataset for Age-related Macular Degeneration (AMD) and successfully
identified two SNPs that were reported to be associated with this disease.
Conclusion:  Besides existing pure statistical approaches, we demonstrated the feasibility of
incorporating machine learning methods into genome-wide case-control studies. The gini
importance offers yet another measure for the associations between SNPs and complex diseases,
thereby complementing existing statistical measures to facilitate the identification of epistatic
interactions and the understanding of epistasis in the pathogenesis of complex diseases.
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Background
Recent advances in human and medical genetics have
made it widely accepted that Mendelian disorders that are
caused by individual genetic variants are rare, whereas
complex diseases that are speculated to be caused by mul-
tiple genetic variants, their interactive effects, and/or their
interactions with environment factors are common [1,2].
The interactive effect between two or more genetic vari-
ants is typically referred to as epistasis, which is supposed
to contribute to complex diseases ubiquitously via the
sophisticated regulatory mechanisms in the molecular
level of human genetics [3]. Biomedical studies have also
been confirming the existence of epistasis in many com-
plex diseases, including myocardial infarction [4], breast
cancer [5], hypertension [6], atrial fibrillation [7], diabe-
tes mellitus type 2 [8], AIDS [9], and many others. The
detection of epistatic interactions therefore plays a key
role in the understanding of the pathogenesis of complex
diseases.
Nevertheless, most statistical approaches that have dem-
onstrated remarkable successes in the detection of genetic
variants underlying Mendelian diseases have impaired
explanatory power in the identification of epistatic inter-
actions responsible for complex diseases [10]. For exam-
ple, family-based linkage analysis that uses a transmission
model to explain the pattern of inheritance of phenotypes
and genotypes exhibited in a pedigree works well for Men-
delian diseases, but it is ineffective when a single locus
fails to explain a significant fraction of a disease [1,2].
On the other hand, with the completion of human
genome project, new opportunities and challenges have
been presented for uncovering the genetic basis of com-
plex diseases via genome-wide association studies [3,11].
With the accumulation of well-phenotyped cases and
carefully selected controls, as well as the emergence of
high-throughput genotyping techniques, it becomes
urgent to develop effective methods for the detection of
epistatic interactions.
To embrace the opportunities, a number of multi-locus
approaches have been developed. For example, Hoh et al
proposed a trimming, weighting, and grouping approach
that used the summation of statistics on the basis of sin-
gle-locus marginal effects and the Hardy-Weinberg equi-
librium (HWE) for hypothesis testing [12]. Nelson et al
put forward a combinatorial partitioning method (CPM)
that exhaustively searched for the combinatorial genotype
group that has the most significant difference in the mean
of the responding continuous phenotype [13]. Culver-
house  et al modified CPM by ignoring partitions that
combined individual genotypes with very different mean
trait values [14]. Millstein et al developed a pre-screening
strategy to reduce the number of tests with the use of a
focused interaction testing framework (FITF) [15]. Chat-
terjee et al used Turkey's 1-degree-of-freedom model to
detect interacting loci from different region [16]. Ritchie et
al adopted an exhaustive search strategy to detect combi-
nations of loci with the highest classification capability
and named their method multifactor-dimensionality
reduction MDR [5]. Zhang and Liu introduced a Bayesian
epistasis association mapping (BEAM) method that inte-
grated a Bayesian model with a Metropolis-Hasting algo-
rithm to infer the probability that each locus was
associated with the susceptibility of a disease [17]. They
also proposed the use of a new B statistic instead of the
standard  χ2 statistic. Many machine learning methods
have also been applied to this research field from the
viewpoint of binary classification and feature selection
[18-24].
The effectiveness of most of these methods for genome-
wide case-control data has not yet been validated. Besides,
many methods rely heavily on the exhaustive search for
combinations of multiple loci. This strategy, though feasi-
ble when the number of candidate SNPs is small, can
hardly be computationally practical for genome-wide
association studies in which the number of candidate
SNPs is typically very huge. For example, a study on Age-
related Macular Degeneration (AMD) has genotyped
more than 100 thousand single nucleotide polymor-
phism (SNP) markers for 96 patients and 50 unaffected
people [25]. It has also become very common to genotype
400~500 thousand SNP markers for hundreds of cases
and controls in recent genome-wide association studies
[26,27]. With such dense SNPs being genotyped, methods
based on the exhaustive search are computationally
impractical due to the vast number of combinations of
SNPs. One of the main challenges for genome-wide asso-
ciation studies is therefore to design computational meth-
ods that are able to reduce the search space for epistatic
interactions from an astronomic number of all possible
combinations of SNPs to a manageable set of candidates.
In this paper, we study case-control data from the view-
point of binary classification. Specifically, we treat cases as
positive samples and controls as negative samples, and we
use SNP markers as categorical features that have three
possible values (i.e., the three genotype values at a locus).
With this notion, we adopt the random forest [28] that has
been widely used in bioinformatics fields such as the
selection of genes [19,20], the identification of gene-gene
interactions [19,22], and the detection of causative non-
synonymous SNPs [29,30] as the classifier to discriminate
cases against controls, with an emphasis on the contribu-
tion of each SNP to the classification performance. For
this purpose, we first run a random forest with all SNPs to
obtain the gini importance of each SNP and then use a slid-
ing window sequential forward feature selection (SWSFS)BMC Bioinformatics 2009, 10(Suppl 1):S65 http://www.biomedcentral.com/1471-2105/10/S1/S65
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algorithm to select a subset of SNPs that can minimize the
classification error. Since this subset typically contains
only a small number of SNPs (e.g., ~100), we are able to
enumerate all possible k-way (k = 1, 2, 3) interactions of
the candidate SNPs and test for statistical significance
their associations with the disease risk.
The above approach, named epiForest (detection of epi-
static interactions using random Forest), was compared
with three existing methods (BEAM [17], the stepwise
logistic regression [11], and the classical χ2 test) on three
simulated disease models [11]. The results showed that
epiForest was comparable to, sometimes more powerful
than, these methods. We further applied the proposed
approach to a genome-wide case-control dataset for AMD
that contains 116,204 SNPs genotyped for 96 cases and 50
controls [25] and selected a subset of 84 SNPs that can
minimize the classification error. Further statistical tests
successfully detected from these candidates two SNPs
(rs380390 and rs1329428) that were reported to be asso-
ciated with this disease.
Results
Principles of epiForest
The classical approach to the detection of single-locus
association fits a full logistic regression model with a
parameter for each observed genotype and then tests the
significance of the fitted model via a χ2 approximation of
the likelihood ratio test statistic [11]. Alternatively, a χ2
test with up to 2 degrees of freedom can be directly
applied to the contingency table that records the number
of cases and controls for each genotype to test whether the
distributions of SNPs for the case and control populations
are significantly different. To ensure the overall type I
error not exceeding a preset significance level α, a Bonfer-
roni correction is typically applied by multiplying the p-
values with the number of SNP markers L (or equivalently
setting the significance level to α/L).
Similarly, in order to detect the epistatic interaction of two
loci, a full logistic regression model with at most 9 param-
eters can be fitted and tested, and the p-values should be
multiplied by L(L-1)/2 according to the Bonferroni correc-
tion [11]. Because the number of SNPs is typically huge
(e.g., several hundred thousand) in genome-wide case-
control studies, an exhaustive search for all possible com-
binations of SNPs is computationally impractical. To
overcome this limitation, the stepwise logistic regression
approach first selects a small fraction (ε, e.g., 10%) of loci
according to the significance of their single-locus associa-
tions and then tests the interactions between the selected
loci [11]. The determination of the fraction ε is, however,
not guided. An approach that is able to automatically
determine such a small set of good candidate markers is
therefore preferred.
For this purpose, we propose to use epiForest, a two-stage
approach as illustrated in Figure 1, for the detection of
epistatic interactions. A case-control study can be thought
of as a binary classification problem, in which we treat
cases as positive samples and controls as negative sam-
ples, and we target on discriminating cases against con-
trols. The SNP markers can be used as categorical features
with three possible values in this classification formula-
tion.
With this notion, in the first stage, we use an ensemble
learning technique called random forest [28] with all
SNPs to do the classification, while the objective is to
obtain the contribution, measured by gini importance, of
each SNP (see Methods). Then, a Sliding Window Sequen-
tial Forward feature Selection (SWSFS) algorithm that adds
one SNP at a time from the most significant SNP to the
least significant one is applied to greedily search for a
small subset of SNPs that could minimize the classifica-
tion error (see Methods). After this step, a small set of l
(<<L, the total number of SNP markers) candidate SNPs
that have the most significant contribution to the discrim-
ination of cases against controls is selected.
In the second stage, a hierarchical procedure is adopted to
declare the statistical significance that the candidate SNPs
are associated with the disease risk. Let α be a preset sig-
nificance level (e.g., 0.05). In the one-way tests, we apply
a statistical test with the use of the B statistic proposed by
Zhang and Liu (see [17] and Methods) to every candidate
SNP and report all SNPs whose p-values are less than α
after Bonferroni corrections for L tests. In the two-way
tests, we apply the B statistic to all two-way interactions of
the candidates, and report interactions whose p-values are
less than α after Bonferroni corrections for L(L-1)/2 tests.
In this procedure, if both SNPs in an interaction have
already been reported in the one-way tests, we skip the test
for their interaction; if one of the SNPs has already been
reported in the one-way tests, we use a conditional B sta-
tistic for testing the interaction; if neither SNPs in an inter-
action has been reported in the one-way tests, we use the
B statistic for testing the interaction. Similarly, in the
three-way tests, we apply the B or conditional B statistics
to all three-way interactions of the candidates, and report
those with p-values less than α after Bonferroni correc-
tions for L(L-1) (L-2)/6 tests.
Performance of epiForest
In order to demonstrate the performance of epiForest, we
compared it with three existing methods, BEAM [17], the
stepwise logistic regression [11], and the standard single-
locus χ2 test, on three simulated disease models.
BEAM uses a Bayesian model with the Metropolis-Hasting
algorithm to partition SNP markers into three groups: aBMC Bioinformatics 2009, 10(Suppl 1):S65 http://www.biomedcentral.com/1471-2105/10/S1/S65
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group G0 containing markers unlinked to the disease, a
group G1 including markers contributing independently
to the disease, and a group G2 that is composed of markers
jointly influencing the disease. After the partition step,
candidate SNPs are further tested for significance with the
use of the B statistic [17]. In BEAM, there are two prior
probabilities need to be pre-determined: the probability
that each marker belongs to G1 and that of G2. In our stud-
ies, we set both priors to 0.001. The stepwise logistic
regression first selects the most significant ε fraction of
SNPs on the basis of their marginal effects, and then tests
all two-way interactions of these SNPs using logistic
regressions with likelihood ratio tests [11]. We use ε =
10% in our studies and further test all three-way interac-
tions of the candidates besides the two-way interactions.
The classical single-locus χ2 test (with at most 2 degrees of
freedom) is used as a benchmark in this comparison.
We considered three disease models with different charac-
teristics (see [11] and [17] for details). Briefly, model 1
contains two disease loci that contribute to the disease risk
independently. Model 2 is similar to model 1, except that
the disease risk is present only when both loci have at least
one disease allele. Model 3 is a threshold model in which
additional disease alleles at each locus do not further
increase the disease risk. Assuming the disease prevalence
to be 0.1 for all disease models, each model has three
parameters associated: the marginal effect of each disease
locus (λ), the minor allele frequencies (MAF) of both dis-
ease loci, and the strength of linkage disequilibrium (LD)
Principles of epi Forest Figure 1
Principles of epi Forest. In the first stage, a random forest is trained with all SNPs to obtain the gini importance of each 
SNP, and a sliding window sequential forward feature selection (SWSFS) algorithm is used to select a subset of candidate SNPs 
that can minimize the classification error. In the second stage, statistical tests on the basis of the B statistics are applied to 
detect significant one-, two-, and three-way epistatic interactions.
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between the unobserved disease locus and a genotyped
locus (r2) [31]. To enumerate all possible combinations of
these parameters is impossible. We therefore selected only
some typical values for each parameter. For λ, we set it to
0.3, 0.5, and 1.0 for model 1, 2, and 3, respectively. For
MAF, we considered four values, 0.05, 0.1, 0.2, and 0.5,
for each model. For r2, we simulated for each model two
values, 0.7 and 1.0. There were therefore 8 parameter set-
tings for each disease model and a total of 24 comparisons
in our simulation studies.
For each parameter setting of each model, we simulated
100 datasets, each of which contains 1,000 markers geno-
typed for 1,000 cases and 1,000 controls. The minor allele
frequency for each non-disease marker is randomly cho-
sen from a uniform [0.0. 0.5] distribution. The perform-
ance of a method on a specific parameter setting is
measured by the power, defined as the fraction of simu-
lated datasets in which all disease loci are identified at the
significance level α = 0.05 after the Bonferroni correction.
The simulation results are shown in Figure 2. An overall
impression is that the power of epiForest is comparable to,
sometimes higher than, that of BEAM and the stepwise
logistic regression, while all these three methods are supe-
rior to the χ2 tests. Specifically, all methods achieve simi-
lar performance in model 1, regardless of the LD strength.
The reason behind this observation is that model 1 is actu-
ally a non-epistasis model, in the sense that the two caus-
ative loci contribute to the disease risk independently.
Therefore, all methods for epistasis detection achieve sim-
ilar performance as the single-locus χ2 test, suggesting that
the more complex models have little effects in this situa-
tion. In model 2, epiForest and BEAM show their superior
performance when the minor allele frequencies of the dis-
ease markers are small. This might be attributed to the
benefit of using the more powerful B statistic. We also
notice that the standard χ2 test, as a single-locus search
method, performs poorly when the minor allele frequen-
cies of the disease markers are small, suggesting the neces-
sity of developing multi-locus approaches in the search
for markers that have epistatic interactions. In model 3,
we have similar observations as in model 2.
Effectiveness of the SWSFS algorithm
The subset of candidate markers that are likely to be asso-
ciated with the disease risk is screened out with the use of
a sliding window sequential forward feature selection
(SWSFS) algorithm, given the gini importance provided
by the initial run of the random forest (see Methods). It is
therefore necessary to see how many markers are typically
selected by this algorithm.
Performance of epi Forest Figure 2
Performance of epi Forest. The power of epiForest is compared with that of BEAM [17], the stepwise logistic regression 
[11], and the χ2 test on 24 parameter settings of 3 disease models. 100 datasets, each containing 1,000 markers for 1,000 cases 
and 1,000 controls, are simulated for each parameter setting. The power is defined as the fraction of datasets in which all dis-
ease loci are identified at the significance level 0.05 after the Bonferroni correction.BMC Bioinformatics 2009, 10(Suppl 1):S65 http://www.biomedcentral.com/1471-2105/10/S1/S65
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For each parameter setting of the disease model, we plot
the number of markers selected by the SWSFS algorithm
in Figure 3. From these box plots, we can see that the
median of the number of selected markers is around 45
for every parameter setting, and the upper bound of this
number is generally less than 80. In other words, the
SWSFS algorithm is capable of shrinking the search space
from 1,000 SNPs to, typically, about 45 markers, thereby
facilitating further statistical tests for epistatic interactions
within this small set of candidates.
In our simulation studies, the power of epiForest is in gen-
eral superior than that of the stepwise logistic regression,
while the parameter ε (the fraction of candidate markers
screened on the basis of their marginal effects) in the step-
wise logistic regression is set to 10% (100 markers), which
is generally greater than the number of candidates sug-
gested by the SWSFS algorithm. These facts suggest that
epiForest can more precisely pinpoint the candidate SNPs
that might be associated with the disease risk, and this
procedure is fully automated.
The observations from Figures 2 and 3 suggest the feasibil-
ity of using machine learning methods to select a set of
candidate markers that are likely to be associated with the
disease risk, thereby reducing the search space for epistatic
interactions from a large number of SNPs to a small
number of selected candidates. Traditional approaches
such as the stepwise logistic regression uses the marginal
importance of individual markers as the criterion to select
the subset of candidate for further exploration, and the
size of the subset remains as a free parameter whose deter-
mination is not guided. With the use of epiForest, how-
ever, the subset is automatically determined as the one
that can minimize the classification error, therefore pro-
viding an automated initial screening. On the other hand,
because the criterion used by epiForest (gini importance)
is intrinsically different from the p-value provided by like-
lihood ratio tests that is used in the stepwise logistic
regression, it is possible that the gini importance can com-
plement statistical criteria to achieve a better search for
epistatic interactions. The results also demonstrate the
power of the B statistic over the likelihood ratio test statis-
tic and the χ2 statistic, because both epiForest and BEAM
are in general more powerful than the stepwise logistic
regression and the χ2 test.
Application to AMD
In simulation studies on 1,000 SNPs, epiForest is compa-
rable to, sometimes more powerful than, three existing
methods. Nevertheless, studies have shown that a number
of 30,000 to 500,000 common SNPs may be required for
genotyping in real genome-wide case-control studies
[32,33]. It is therefore necessary to show whether epiForest
Number of SNP markers selected by epi Forest Figure 3
Number of SNP markers selected by epi Forest. The median of the number of markers selected by the sliding window 
sequential forward feature selection (SWSFS) algorithm is around 45, while the maximum is in general less than 80, suggesting 
the capacity of the SWSFS algorithm.BMC Bioinformatics 2009, 10(Suppl 1):S65 http://www.biomedcentral.com/1471-2105/10/S1/S65
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is able to handle such large data in real genome-wide asso-
ciation studies.
For this purpose, we applied epiForest to an Age-related
Macular Degeneration (AMD) dataset [25], which con-
tained 116,204 SNPs genotyped with 96 cases and 50 con-
trols. As suggested in [25], we removed nonpolymorphic
SNPs and those that significantly deviated from Hardy-
Weinberg Equilibrium (HWE), and we removed all SNPs
that had no reference SNP ID or had more than 5 missing
genotypes to ensure the high quality of the remaining
data. After the filtering, there remained 95,986 SNPs.
We first run a random forest with the use of all SNPs as
categorical features to discriminate the 96 cases against
the 50 controls. The aim was to obtain the gini impor-
tance, indicating the contribution to the classification
accuracy, of each SNP. We used one million trees in the
construction of the random forest and repeated the exper-
iment ten times to reduce random effects. The gini impor-
tance for each SNP was averaged over the resulting ten
forests and shown in Figure 4.
It is interesting to see from this figure that the two SNPs,
rs380390 and rs1329428, that were reported to be associ-
ated with AMD in literature [25], have the largest gini
importance among all SNPs. Specifically, the gini impor-
tance is 2.73 for rs380390 and 2.44 for rs1329428, while
the Bonferroni-corrected p-values are 0.0043 and 0.14 for
rs380390 and rs1329428, respectively, according to χ2
tests under the assumption of Hardy-Weinberg equilib-
rium [25]. These observations suggest that higher gini
importance may indicate lower p-value.
We then plotted the relationship between the gini impor-
tance values and the p-values (without Bonferroni correc-
tion) for B statistics of all the 95,986 SNPs in Figure 5. We
observed that, in general, larger gini importance values
imply smaller p-values. In other words, the gini impor-
tance has a strong negative correlation with the p-value. In
details, their Pearson's correlation coefficient (PCC) is -
0.59, and is very significant with a p-value less than 2.2 ×
10-16 (given by R). This observation suggests that the gini
importance from the viewpoint of machine learning may
complement the p-value from the statistics point of view
to offer yet another measure for the associations between
SNPs and complex diseases.
To illustrate the sliding window sequential forward fea-
ture selection (SWSFS) algorithm, we plotted the classifi-
cation error rate of random forests using up to the first
2,000 most important SNPs, as shown in Figure 6. The
minimum classification error (8.5%) occurs when the first
84 most important SNPs (on the basis of their gini impor-
tance) are used. With the use of the SWSFS algorithm
(window-size setting to 20, see Methods), only the first
104 random forests need to be constructed, therefore sav-
ing the computational expenses. It is worth noting that
the minimal classification error, the number of the SNPs
used, and the subset of SNPs are automatically deter-
mined by the SWSFS algorithm without the participation
of human. When compared with the stepwise logistic
regression method in which the fraction of candidate
Relationship between the gini importance and the p-value for  the B statistic Figure 5
Relationship between the gini importance and the p-
value for the B statistic. x-axis is the logarithm (base 10) 
of the p-value for the B statistic. y-axis is the gini importance.
Gini importance of the SNPs in the AMD dataset Figure 4
Gini importance of the SNPs in the AMD dataset. x-
axis is the index of SNP markers. y-axis is the gini impor-
tance. The two circles represent the two SNPs that are 
already identified in literature [25].BMC Bioinformatics 2009, 10(Suppl 1):S65 http://www.biomedcentral.com/1471-2105/10/S1/S65
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markers need to be manually determined for further
investigation, our approach can provide an automated
means of determining this critical value.
There has yet no report about interactions associated with
AMD from this dataset thus far. The main reason might be
the small sample size of 146 individuals is insufficient for
detecting subtle epistatic interactions [17]. In our study,
we also find no significant interactions after the Bonfer-
roni correction. Nevertheless, we still report in Table 1 the
top 5 two-way interactions and the top 5 three-way inter-
actions that have the smallest p-values before the Bonfer-
roni correction. It is interesting to see that neither
rs6104678 nor rs7863587 is significant for single-locus
association (actually there are 9 SNPs having smaller p-
values then rs6104678 and 14 SNPs being more signifi-
cant than rs7863587), whereas their combination has the
smallest p-value among all two-way interactions. We can
also see that rs1394608 appears in 3 out of 5 two-way
interactions, and rs7104698 appears in all 5 three-way
interactions. Certainly, these observations need to be fur-
ther studied in depth with the use of more case-control
samples, and functional tests are necessary to confirm
whether these interactions have true associations with
AMD. Although these studies are beyond the scope of this
paper, we hope that, from Table 1, some clues could be
provided for the exploration of epistatic interactions in
this complex disease. Note that, some of these interac-
tions have been previously detected independently by
another genome-wide association study method that is
developed by the authors to identify epistatic modules via
the integration of Bayesian models and Markov Chain
Monte Carlo strategies.
Discussion
The development of epiForest is motivated by the follow-
ing two facts: (1) most existing approaches use pure statis-
tical methods and (2) in the stepwise logistic regression,
the selection for the subset of candidate SNPs is not
guided. Accordingly, the main contribution of our
approach includes: (1) the incorporation of the random
forest into case-control studies and (2) the automated
screening of the candidate SNPs for further statistical anal-
ysis.
The random forest has several advantages over other clas-
sifiers in the studies for case-control data. First, and of the
most interest, the random forest can natively provide the
gini importance that measures the contribution of indi-
vidual features (SNPs) to the classification. We have also
shown that the correlation between this importance
measure and the p-value for the B statistic is strongly neg-
ative. In this sense, the gini importance may complement
the p-value to offer yet another useful measure for the
associations between SNPs and complex diseases. Second,
the random forest needs no extra cross-validation for eval-
uating the classification performance, thereby greatly
reducing the computational time. Third, as a classical
ensemble learning method, the procedures for construct-
ing decision trees in the forest are mutually independent,
hence very suitable for large scale parallel computation or
hardware acceleration.
The epiForest framework can also be extended from the
following directions. First, the gini importance can itself
serve as a statistic and be used with the permutation test
to directly offer a p-value. Second, the random forest has
an experimental means of estimating interactions
between two features. For each tree, features can be ranked
on the basis of their gini decreases, and the absolute dif-
ference in the ranks of every two features can be calcu-
lated. Averaging this difference over all trees, one obtains
a measure for the interaction of every pair of features [17].
It is therefore interesting to analyze the relationship
between this measure and statistical measures such as the
p-value.
Certainly, our approach is not intended to take the place
of existing statistical methods for detecting epistatic inter-
actions. Instead, we are interested in showing how
machine learning approaches can complement statistical
methods to facilitate the exploration of interactions
between multiple SNPs, because epistasis plays such an
important role in the pathogenesis of complex diseases,
Classification error rates of random forests using up to the  first 2,000 most important SNPs Figure 6
Classification error rates of random forests using up 
to the first 2,000 most important SNPs. x-axis is the 
number of SNP markers used. y-axis is the classification error 
rate given by the random forest (one million trees). The cir-
cle (with 84 markers and an error rate of 8.5%) represents 
the minimum in this curve.BMC Bioinformatics 2009, 10(Suppl 1):S65 http://www.biomedcentral.com/1471-2105/10/S1/S65
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and the detection of epistasis still remains a great chal-
lenge and needs to be studied from different perspectives.
Conclusion
In this paper, we studied case-control data from the view-
point of binary classification. We treated cases as positive
samples and controls as negative samples, and used SNP
markers as categorical features. We adopted random forest
to discriminate cases against controls, while the focus was
to obtain the gini importance to measure the contribution
of each SNP to the classification performance. On the
basis of this measure, a sliding window sequential for-
ward feature selection (SWSFS) algorithm was proposed
to automatically determine a subset of candidate SNPs
that were most likely to be associated with the disease. A
hierarchical procedure with the use of the B statistic was
applied to declare statistical significance of up to three-
way interactions within this set of candidates. This frame-
work, including the random forest and the SWSFS algo-
rithm for initial screening, and the hierarchical procedure
for declaring statistical significance, was named epiForest.
We compared the proposed approach with three existing
methods, including BEAM [17], the stepwise logistic
regression [11], and the χ2 test, on three simulated disease
models [11]. The results showed that the power of epiFor-
est was comparable to, sometimes higher than, that of the
other methods.
We further applied epiForest to a real genome-wide case-
control dataset of AMD. The SWSFS algorithm automati-
cally selected a set of 84 SNP markers. It was interesting to
see that the two SNPs (rs380390 and rs1329428) already
reported as linked to this disease [25] had the highest gini
importance. A strong negative correlation between the
gini importance and the p-value for the B statistic was also
observed.
Methods
Random forest
The random forest is an ensemble learning methodology
originated by Leo Breiman (see [28] for details). The basic
idea of ensemble learning is to boost the performance of
a number of weak learners via a voting scheme, where a
weak learner can be an individual decision tree, a single
perceptron/sigmoid function, or other simple and fast
classifiers. As for the random forest, its hallmarks mainly
include (1) bootstrap resampling, (2) random feature
selection, (3) full depth decision tree growing, and (4)
Out-of-bag (OOB) error estimate.
Given a set of N binary labelled training samples, where xi
(i = 1, 2,..., N) is a vector of predictor variables (features)
and yi the response variable (class label), a random forest
targets on generating a number of M decision trees from
these samples. For each tree, the same number of N sam-
ples is randomly selected with replacement (bootstrap
resampling) to form a new training set, and the samples
not selected are called out-of-bag (OOB) samples. Using
this new training set, a decision tree is grown to the largest
extent possible without any pruning according to the
CART methodology [34], while in the split of each node,
only a small number of m  randomly selected features
instead of all predictor variables is considered (random
feature selection). Repeating the creation of a decision tree
M times, we have a number of M distinct decision trees,
forming a randomly generated "forest."
Unlike most machine learning methods that need to
resort to cross-validation for the estimation of classifica-
tion error, the random forest can natively estimate an out-
of-bag (OOB) error in the process of constructing the for-
est, and this estimate is claimed to be unbiased in many
tests [28]. With the construction of a decision tree, each
OOB sample is tested, and its (OOB) classification result
is collected. Upon the finish of constructing the entire for-
est, OOB classification results for each sample are used to
determine a decision for this sample via a majority voting
rule. The fraction of decisions that disagree with the true
class label is then the OOB error estimate.
These characteristics make the random forest suitable for
handling large-scale samples with thousands of features
and thus gaining a wide spectrum of applications in bio-
informatics such as the selection of genes [19,20], the
identification of gene-gene interactions [19,22], and the
detection of causative nonsynonymous SNPs [29,30]. In
our studies, we use the "randomForest" package in R. The
number of trees (M) and the number of features randomly
selected in each node (m) are referred to as ntree and mtry
(with the default value  ) in this package, #{ } SNPs ⎢ ⎣ ⎥ ⎦
Table 1: Top 5 two-way and top 5 three-way interactions in AMD 
that have the smallest p-values (for the B statistics) before the 
Bonferroni correction.
SNP Interaction p-value
(rs6104678, rs7863587) 1.28 × 10-7
(rs3743175, rs1394608) 3.06 × 10-7
(rs2828155, rs1394608) 3.06 × 10-7
(rs4292478, rs1394608) 7.29 × 10-7
(rs6104678, rs10512174) 7.68 × 10-7
(rs2347060, rs3758141, rs7104698) 5.57 × 10-9
(rs2347061, rs3758141, rs7104698) 5.57 × 10-9
(rs2347060, rs10503640, rs7104698) 6.91 × 10-9
(rs2347061, rs10503640, rs7104698) 6.91 × 10-9
(rs2347060, rs1557753, rs7104698) 1.07 × 10-8BMC Bioinformatics 2009, 10(Suppl 1):S65 http://www.biomedcentral.com/1471-2105/10/S1/S65
Page 10 of 12
(page number not for citation purposes)
respectively. Detailed discussion about the effects of these
parameters to the classification performance can be found
in [20] and [28].
Gini importance
Suppose that η, a node of a decision tree T, contains a
number of n samples, in which n0 are negative and n1 = n
- n0 are positive. The relative frequencies of the negative
and positive samples, f0 and f1, respectively, can then be
estimated as
f0 = n0/n and f1 = n1/n1/n,
and the gini impurity of this node, Φ(η), can be calculated
as
This formula can be generalized to account for three or
more classes [34]. Now, for a split at this node that yields
two sub-nodes ηl and ηr, the decrease of the gini impurity
for this split is calculated as
ΔΦ(η) = Φ(η) - fl Φ(ηl) - fr Φ(ηr),
where fl and fr are the fractions of samples in η that fall
into ηl and ηr, respectively. Since the split is happen on a
certain feature v, this decrease in gini impurity is also
defined as the gini decrease for v at the node η. Moreover,
v may be used as the splitting variable in more than one
node. Let I (η, v) be the indicator function that is equal to
1 when v is the splitting variable of η and 0 otherwise. The
gini decrease of v in this tree is then defined as the sum-
mation of gini decreases for all nodes in which v is the
splitting variable, as
where  NT is the collection of all nodes of the tree T.
Finally, the summation of all gini decrease of v over all
trees in the forest is the gini importance of v, as
where T is the collection of all decision trees in the ran-
dom forest.
The random forest provides another randomization
mechanism to estimate the importance of individual fea-
tures. When a decision tree is constructed, the correct clas-
sifications for the OOB samples can be counted. Now, for
a feature v, randomly permute its values in the OOB sam-
ples and again count the correct classifications. The aver-
age of the difference in these two counts over all trees in a
forest is then defined as the raw importance of the feature v.
It has been shown that the gini importance and the raw
importance are very consistent [28], but the computation
of the gini importance is much more economy. We there-
fore adopt the gini importance to measure the contribu-
tion of a SNP to the classification performance in our
studies.
Sliding window sequential forward feature selection
The key step in epiForest is to automatically determine a
subset of candidate SNPs that are likely to be linked to the
disease. We use a sliding window sequential forward fea-
ture selection (SWSFS) algorithm on the basis of the gini
importance for this purpose.
Suppose that M = {m1,..., mL}. are a number of L markers,
and through an initial run of a random forest, the gini
importance for these markers has been obtained as G =
{g1,..., gL} , where gi = GI(mi). Besides, the order of these
markers on the basis of the importance is obtained as O =
{o1,..., oL}, that is, for every (i, j) that satisfies 1 ≤ i <j ≤ L,
. In other words,   is the most important
marker,   the second most important one, and so
forth. A Naïve Greedy Sequential Forward feature Selection
(NGSFS) algorithm can then be designed as follows:
Naïve Greedy SFS
1.  i := 1; k := 1;
2. WHILE  (i ≤ L) DO
3. Error  [i] := randomForest(M [o1,..., oi]);
4.  IF (Error [i] < Error [k])
5.  k := i;
6. END  IF
7. END  WHILE
8. RETURN  M [o1,..., ok];
Here, M [o1,..., oi] is the subset of the first i most important
SNPs, M [o1,..., ok] the subset of selected SNPs, and k the
number of selected SNPs.
This algorithm greedily searches for a subset of SNPs that
can minimize the classification error instead of enumerat-
Φ() . η =−− () = 12 0
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2
01 ff f f
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ing all 2L - 1 nonempty subsets of the L SNPs. However,
when L is huge, even this algorithm is computationally
intractable. In our studies, we find that the classification
errors produced by the NGSFS have a "V" shape with
many local minimum, and the true global minimum is
typically produced when only a small number of the most
important SNPs are used (see Figure 6 as an example).
Also, the construction of a random forest with fewer fea-
tures is faster. These observations motivate us to propose
the following Sliding Window Sequential Forward feature
Selection (SWSFS) algorithm:
Sliding Window SFS
1.  i =: 1; k =: L; w =: 20;
2. WHILE  (i ≤ L) DO
3. Error  [i] =: randomForest(M [o1,..., oi]);
4. IF  (i > w AND i - w = argmini-w ≤ j ≤ i {Error [j]})
5.  k =: i - w;
6 BREAK;
7. END  IF
8. END  WHILE
9. RETURN  M [o1,..., ok];
This algorithm greedily searches for the first subset of
markers in which the left boundary should have the min-
imal classification error in a window of size w. The win-
dow size determines how robust the algorithm could be,
and we simply set it to 20 in this paper.
Statistical tests
We adopt a hierarchical procedure on the basis of the B
statistic [17] in the second stage of epiForest to declare sta-
tistical significance of up to three-way interactions within
the candidate SNPs that are selected by the SWSFS algo-
rithm.
There are two motivations for using the B statistic: (1) it is
more powerful than the standard χ2 statistic, and (2) the
marginal effects of already reported individual SNPs or
partial interactions can be handled via the use of a condi-
tional B statistic. Here we briefly introduce the B staistic,
while the detailed derivation should refer to [17].
Given a set Ω of k markers, we like to test the hypothesis
H0: SNPs in Ω are not associated with the disease versus
H1: SNPs in Ω are jointly linked to the disease. For this
purpose, a B statistic is defined as
BΩ = ln [P1(DΩ, UΩ)/P1(DΩ, UΩ)],
where DΩ and UΩ are the observed case and control data
for the set of markers, respectively, and P1(DΩ, UΩ) and
P0(DΩ, UΩ) are Bayesian factors (marginal probabilities of
the data) under the alternative and the null hypotheses,
respectively.
More specifically, P1 (DΩ, UΩ) is calculated as
P1 (DΩ, UΩ) = Pjoin (DΩ [Pind (UΩ) + Pjoin (UΩ)],
and P0(DΩ, UΩ) is calculated as
P0 (DΩ, UΩ) = Pind(DΩ, UΩ) + Pjoin(DΩ, UΩ).
Here,
and
In the above formulae, αj and βj are pseudo-counts with
default values 0.5 (see [17]), nij the number of controls
that have the j-th genotype at the i-th SNP, and nj the
number of controls that have the j-th combinatory geno-
type. Pjoin(DΩ), Pind(DΩ, UΩ), and Pjoin(DΩ, UΩ) can be cal-
culated in a similar way. These formulae are derivation
from a Bayesian marker partition model in [17]. It has
been shown that under the null hypothesis, 2BΩ  has
asymptotically a shifted χ2 distribution with 3k - 1 degrees
of freedom. A p-value can therefore be calculated using the
χ2 distribution.
Give a subset ω of Ω, where the t markers in ω are linked
to the disease through either individual and/or partial
interactive effects. A conditional B statistic, BΩ|ω, for the
rest markers can then be calculated in a similar way as the
B statistic. Furthermore, under the null hypothesis that
the rest markers are unlinked to the disease, 2BΩ|ω follows
asymptotically a shifted χ2 distribution with 3k -3t degrees
of freedom. A p-value can then be calculated accordingly.
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